| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00062752-200311000-00009 |
| P953 | full work available at URL | https://journals.lww.com/00062752-200311000-00009 |
| P698 | PubMed publication ID | 14564176 |
| P5875 | ResearchGate publication ID | 9046993 |
| P50 | author | Kieren A Marr | Q90630865 |
| P2860 | cites work | Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 |
| Azole cross-resistance in Aspergillus fumigatus | Q28345187 | ||
| Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review | Q33972694 | ||
| Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. | Q33980029 | ||
| Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. | Q51195797 | ||
| Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. | Q51700168 | ||
| Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. | Q52588180 | ||
| Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. | Q54071912 | ||
| Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. | Q54116723 | ||
| Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. | Q54251450 | ||
| Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients | Q58865962 | ||
| Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation | Q59512032 | ||
| A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group | Q73165218 | ||
| Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning | Q73256320 | ||
| Zygomycosis in the 1990s in a tertiary-care cancer center | Q73893355 | ||
| Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital | Q77627982 | ||
| Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies | Q78410377 | ||
| Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid | Q78734994 | ||
| Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate | Q33983618 | ||
| Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections | Q34100318 | ||
| Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation | Q34121622 | ||
| Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies | Q34162934 | ||
| Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis | Q34196640 | ||
| Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. | Q34243482 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients | Q34553509 | ||
| Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase | Q34823914 | ||
| Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer | Q34880358 | ||
| Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients | Q34990441 | ||
| Use of amphotericin B with azole antifungal drugs: what are we doing? | Q35117932 | ||
| Th1 and Th2 cytokines in mice with invasive aspergillosis. | Q35567104 | ||
| Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis | Q35636789 | ||
| In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. | Q39651019 | ||
| Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis | Q39652561 | ||
| The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro | Q39652699 | ||
| In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. | Q39652771 | ||
| A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus | Q39731994 | ||
| In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points | Q39743420 | ||
| Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei | Q39743425 | ||
| Killing activity of micafungin against Aspergillus fumigatus hyphae assessed by specific fluorescent staining for cell viability | Q39755556 | ||
| High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation | Q40568921 | ||
| Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients | Q40572100 | ||
| Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients | Q40585861 | ||
| Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study | Q40627960 | ||
| Contamination of hospital water with Aspergillus fumigatus and other molds. | Q43352093 | ||
| T cell vaccination in mice with invasive pulmonary aspergillosis. | Q43413736 | ||
| Airborne outbreak of nosocomial Scedosporium prolificans infection | Q43647858 | ||
| Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial | Q43801360 | ||
| Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis | Q43864353 | ||
| Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans | Q43933917 | ||
| Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate | Q44062197 | ||
| Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis | Q44116601 | ||
| Comparison of caspofungin and amphotericin B for invasive candidiasis | Q44255071 | ||
| Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin | Q44304226 | ||
| Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections | Q44417870 | ||
| A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. | Q44440960 | ||
| Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin | Q44469440 | ||
| Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants | Q44482347 | ||
| Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece | Q46233381 | ||
| Invasive mold infections in allogeneic bone marrow transplant recipients. | Q51192154 | ||
| Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. | Q51192216 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | invasive fungal infections | Q55022218 |
| P304 | page(s) | 445-450 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Current Opinion in Hematology | Q15757961 |
| P1476 | title | New approaches to invasive fungal infections | |
| P478 | volume | 10 |
Search more.